<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">15631</article-id><article-id pub-id-type="doi">10.15789/2220-7619-MAM-15631</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Microbiological and molecular genetic characteristics of Klebsiella pneumoniae isolates, extracted under conditions of cardiac surgery hospital</article-title><trans-title-group xml:lang="ru"><trans-title>Микробиологическая и молекулярно-генетическая характеристика изолятов Klebsiella pneumoniae, выделенных в условиях кардиохирургического стационара</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kuznetsova</surname><given-names>M. V.</given-names></name><name xml:lang="ru"><surname>Кузнецова</surname><given-names>М. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Leading Researcher, Laboratory of Molecular Biotechnology</p></bio><bio xml:lang="ru"><p>д.м.н., ведущий научный сотрудник лаборатории молекулярной биотехнологии</p></bio><email>mar@iegm.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sergevnin</surname><given-names>V. I.</given-names></name><name xml:lang="ru"><surname>Сергевнин</surname><given-names>В. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>DSc (Medicine), Professor, Department of Epidemiology and Hygiene</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры эпидемиологии и гигиены</p></bio><email>mar@iegm.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mikhailovskaya</surname><given-names>V. S.</given-names></name><name xml:lang="ru"><surname>Михайловская</surname><given-names>В. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Bachelor, Engineer, Laboratory of Molecular Biotechnology</p></bio><bio xml:lang="ru"><p>бакалавр, инженер лаборатории молекулярной биотехнологии</p></bio><email>mar@iegm.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kudryavtseva</surname><given-names>L. G.</given-names></name><name xml:lang="ru"><surname>Кудрявцева</surname><given-names>Л. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Head of the Epidemiological Department</p></bio><bio xml:lang="ru"><p>к.м.н., врач-эпидемиолог, зав. эпидемиологическим отделом</p></bio><email>mar@iegm.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pegushina</surname><given-names>О. G.</given-names></name><name xml:lang="ru"><surname>Пегушина</surname><given-names>О. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Bacteriologist</p></bio><bio xml:lang="ru"><p>врач-бактериолог</p></bio><email>mar@iegm.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of Ecology and Genetics of Microorganisms Ural Branch Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт экологии и генетики микроорганизмов УрО РАН — филиал Пермского федерального исследовательского центра УрО РАН</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Perm State Medical University named after academician E.A. Wagner</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Пермский государственный медицинский университет имени академика Е.А. Вагнера Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Cardiovascular Surgery Federal Center named after S.G. Sukhanov Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ Федеральный центр сердечно-сосудистой хирургии имени С.Г. Суханова Минздрава России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-12-13" publication-format="electronic"><day>13</day><month>12</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-02-28" publication-format="electronic"><day>28</day><month>02</month><year>2024</year></pub-date><volume>14</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>103</fpage><lpage>114</lpage><history><date date-type="received" iso-8601-date="2023-08-17"><day>17</day><month>08</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-12-07"><day>07</day><month>12</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Kuznetsova M.V., Sergevnin V.I., Mikhailovskaya V.S., Kudryavtseva L.G., Pegushina О.G.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Кузнецова М.В., Сергевнин В.И., Михайловская В.С., Кудрявцева Л.Г., Пегушина О.Г.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Kuznetsova M.V., Sergevnin V.I., Mikhailovskaya V.S., Kudryavtseva L.G., Pegushina О.G.</copyright-holder><copyright-holder xml:lang="ru">Кузнецова М.В., Сергевнин В.И., Михайловская В.С., Кудрявцева Л.Г., Пегушина О.Г.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/15631">https://iimmun.ru/iimm/article/view/15631</self-uri><abstract xml:lang="en"><p><italic>Klebsiella pneumoniae </italic>is one of the main causative agents of healthcare-associated infections (HAI) worldwide. The study was aimed at molecular characterization of beta-lactam antibiotic resistance in <italic>K. pneumoniae</italic> isolated in the cardiac surgery hospital, identify hypervirulent isolates and assess isolate genetic relatedness. <italic>K. pneumoniae</italic> isolated from the clinical material of patients (n = 50) at cardiac surgery departments as well as anesthesiology and reanimation department treated at the cardiovascular surgery hospital in Perm from July 2021 to December 2022 were analyzed. Bacteriological studies were performed on an automatic analyzer WalkAway-96Plus (Beckman Coulter, USA). The sensitivity to thirteen antimicrobials, production of extended-spectrum beta-lactamases (ESBL) and multidrug resistance (MDR) phenotype were assessed. The string test was used to screen hypermucoviscous <italic>K. pneumoniae</italic>. Isolate relatedness (ERIC-PCR), presence of beta-lactamase genes (<italic>bla</italic><sub>TEM</sub>, <italic>bla</italic><sub>CTX-M</sub>, <italic>bla</italic><sub>SHV</sub>, <italic>bla</italic><sub>OXA</sub>, <italic>bla</italic><sub>KPC</sub>, <italic>bla</italic><sub>VIM-2</sub>, <italic>bla</italic><sub>IMP-1</sub>, <italic>bla</italic><sub>NDM-1</sub>), as well as genes associated with hypervirulence <italic>(prmpA, iucA, peg-344, wzyK2, magA)</italic> were analyzed by PCR. Amplifications were performed in a DNA Engine Dyad Thermal Cycler (Bio-Rad, USA). Gel documentation system Gel-Doc XR (Bio-Rad, USA) was used for band visualization and data documentation. According to the study results, it was found that carbapenem-resistant isolates accounted for almost 76% of all isolates, the ESBL-phenotype had 90%, and MDR-phenotype — 88% of studied isolates. According to the string test results, 8% of <italic>K. pneumoniae</italic> isolates had a hypermucoviscous phenotype. As for genes associated with hypervirulence, it was shown that the <italic>iucA</italic> gene was the most common, amplified in 54% of isolates, <italic>prmpA</italic> was detected in 38% of isolates, 48% of isolates had <italic>wzyK2</italic> or <italic>magA</italic> genes encoding capsular type K1/K2. Almost a third of <italic>K. pneumoniae</italic> samples contained a combination of the <italic>rmpA</italic> and <italic>iucA</italic> genes, and they were isolated more often in the group of patients with active infection. Only carbapenem-sensitive microorganisms had hypermucoviscous phenotype, K1 capsular type, and a combination of <italic>prmpA, iucA, peg-344</italic> genes, whereas the K2 capsular type was most common among carbapenem-resistant <italic>K. pneumoniae</italic>. Based on molecular genetic typing, it was found that 24% of <italic>K. pneumoniae</italic> isolates were assigned to four genome groups of identical cultures, 76% of the isolates had individual profiles. Closely related isolates were found among patients from different departments that indicates a potential pathogen circulation in the closed circuit “surgery department–department of anesthesiology” and “reanimation–surgery department”.</p></abstract><trans-abstract xml:lang="ru"><p><italic>Klebsiella pneumoniae </italic>является одним из основных возбудителей инфекций, связанных с оказанием медицинской помощи (ИСМП), во всем мире. Цель исследования: молекулярно-генетическая характеристика устойчивости к бета-лактамным антибиотикам культур <italic>K. pneumoniae</italic>, выделенных в условиях кардиохирургического стационара, выявление гипервирулентных изолятов, а также оценка генетического родства культур. Были изучены изоляты, выделенные из клинического материала пациентов (n = 50) кардиохирургических отделений и отделения анестезиологии и реанимации (ОАиР), находившихся на лечении в кардиохирургическом стационаре г. Перми с июля 2021 г. по декабрь 2022 г. Бактериологические исследования были выполнены на автоматическом анализаторе «WalkAway-96Plus» (Beckman Coulter, США). Определена чувствительность культур к тринадцати антимикробным препаратам и продукция бета-лактамаз расширенного спектра (БЛРС), оценен фенотип множественной лекарственной устойчивости (МЛУ). Для определения гипермукоидного фенотипа <italic>K. pneumoniae</italic> использовали стринг-тест. Родственность изолятов (ERIC-ПЦР), присутствие генов бета-лактамаз (<italic>bla</italic><sub>TEM</sub>, <italic>bla</italic><sub>CTX-M</sub>, <italic>bla</italic><sub>SHV</sub>, <italic>bla</italic><sub>OXA</sub>, <italic>bla</italic><sub>KPC</sub>, <italic>bla</italic><sub>VIM-2</sub>, <italic>bla</italic><sub>IMP-1</sub>, <italic>bla</italic><sub>NDM-1</sub>), а также генов, ассоциированных с гипервирулентностью <italic>(prmpA, iucA, peg-344, wzyK2, magA)</italic>, определяли методом ПЦР по конечной точке. Амплификацию проводили на термоциклере «DNA Engine Dyad Thermal Cycler» (Bio-Rad, США), визуализацию полос и документирование данных осуществляли с помощью системы гель-документации «Gel-Doc XR» (Bio-Rad, США). По результатам исследования установлено, что карбапенемоустойчивые <italic>K. pneumoniae</italic> составили почти 76% всех культур, фенотип БЛРС имели 90%, а МЛУ — 88% изолятов. Среди определенных бета-лактамаз наиболее широко в коллекции культур были представлены ферменты типов СТХ-М, VIM-2 и NDM-1, гены которых часто локализованы на мобильных генетических элементах, обеспечивающих быстрое внутри- и межвидовое распространение. Согласно результатам стринг-теста, гипермукоидный фенотип имели 8% изолятов <italic>K. pneumoniae</italic>. В отношении генов, ассоциированных с гипервирулентностью, показано, что наиболее распространенным оказался ген <italic>iucA</italic>, амплифицированный у 54% изолятов, <italic>prmpA</italic> детектировали у 38% культур, 48% культур имели гены <italic>wzyK2</italic> или <italic>magA</italic>, маркирующие капсулы типа К1/К2. Почти треть <italic>K. pneumoniae</italic> содержали комбинацию генов <italic>rmpA</italic> и <italic>iucA</italic>, при этом выделяли их чаще в группе пациентов с активной инфекцией. Гипермукоидный фенотип, капсульный тип К1 и комбинацию генов <italic>prmpA</italic>, <italic>iucA</italic>, <italic>peg-344</italic> имели только чувствительные к карбапенемам культуры, тогда как капсульный тип К2 был наиболее распространен среди устойчивых к карбапенемам <italic>K. pneumoniae</italic>. На основании молекулярно-генетического типирования выявлено, что 24% культур <italic>K. pneumoniae</italic> распределились в 4 геномогруппы идентичных изолятов, 76% культур имели индивидуальные профили. Обнаружены близкородственные изоляты у пациентов разных отделений, что указывает на возможную циркуляцию возбудителя в замкнутом контуре «отделение–ОАиР–отделение».</p></trans-abstract><kwd-group xml:lang="en"><kwd>Klebsiella pneumoniae</kwd><kwd>cardiac surgery hospital</kwd><kwd>molecular typing</kwd><kwd>extended beta-lactamase spectrum</kwd><kwd>carbapenemase</kwd><kwd>hypervirulence</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Klebsiella pneumoniae</kwd><kwd>кардиохирургический стационар</kwd><kwd>молекулярное типирование</kwd><kwd>бета-лактамазы расширенного спектра</kwd><kwd>карбапенемазы</kwd><kwd>гипервирулентность</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">НИОКТР</institution></institution-wrap><institution-wrap><institution xml:lang="en">Research &amp;amp; Development program</institution></institution-wrap></funding-source><award-id>124020500028-4</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Агеевец В.A., Агеевец И.В., Сидоренко С.В. Конвергенция множественной резистентности и гипервирулентности у Klebsiella pneumoniae // Инфекция и иммунитет. 2022. Т. 12, № 3. C. 450–460. [Ageevets V.A., Ageevets I.V., Sidorenko S.V. Convergence of multiple resistance and hypervirulence in Klebsiella pneumoniae. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2022, vol. 12, no. 3, pp. 450–460. (In Russ.)] doi: 10.15789/2220-7619-COM-1825</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Алексеева А.Е., Бруснигина Н.Ф., Гординская Н.А. Молекулярно-генетическая характеристика карбапенем-устойчивого штамма Klebsiella pneumoniae KP254 как представителя эволюционной ветки высоковирулентных штаммов // Инфекция и иммунитет. 2021. Т. 11, № 3. C. 506–516. [Alekseeva A.E., Brusnigina N.F., Gordinskaya N.A. Molecular genetic characteristics of the carbapenem-resistant Klebsiella pneumoniae KP254 strain as a representative of the highly virulent strain evolutionary branch. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2021, vol. 11, no. 3, pp. 506–516. (In Russ.)] doi: 10.15789/2220-7619-MGC-1480</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Егорова С.А., Кафтырева Л.А., Липская Л.В., Коноваленко И.Б., Пясетская М.Ф., Курчикова Т.С., Ведерникова Н.Б., Морозова О.Т., Смирнова М.В., Попенко Л.Н., Любушкина М.И., Савочкина Ю.А., Макарова М.А., Сужаева Л.В., Останкова Ю.В., Иванова М.Н., Павелкович А.М., Наабер П., Сепп Э., Кыльялг С., Мицюлявичене И., Балоде А. Штаммы энтеробактерий, продуцирующие бета-лактамазы расширенного спектра и металло-β-лактамазу ndm-1, выделенные в стационарах в странах Балтийского региона // Инфекция и иммунитет. 2013. Т. 3, № 1. С. 29–36. [Egorova S.A., Kaftyreva L.A., Lipskaya L.V., Konovalenko I.B., Pyasetskaya M.F., Kurchikova T.S., Vedernikova N.B., Morozova O.T., Smirnova M.V., Popenko L.N., Lyubushkina M.I., Savochkina Yu.A., Makarova M.A., Suzhaeva L.V., Ostankova Yu.V., Ivanova M.N., Pavelkovich A.M., Naaber P., Sepp E., Kyl’yalg S., Mitsyulyavichene I., Balode A. Enterobacteriacae, producing ESBLs and metallo-β-lactamase NDM-1, isolated in hospitals of Baltic region countries. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2013, vol. 3, no. 1, pp. 29–36. (In Russ.)] doi: 10.15789/2220-7619-2013-1-29-36</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Лазарева И.В., Агеевец В.А., Ершова Т.А., Зуева Л.П., Гончаров А.Е., Дарьина М.Г., Светличная Ю.С., Усков А.Н., Сидоренко С.В. Распространение и антибактериальная резистентность грамотрицательных бактерий, продуцентов карбапенемаз, в Санкт-Петербурге и некоторых других регионах Российской Федерации // Антибиотики и химиотерапия. 2000. Т. 61. С. 11–12. [Lazareva I.V., Ageevets V.A., Ershova T.A., Zueva L.P., Goncharov A.E., Darina M.G., Svetlichnaya Yu.S., Uskov A.N., Sidorenko S.V. Distribution and antibacterial resistance of gram-negative bacteria, producers of carbapenemases, in St. Petersburg and some other regions of the Russian Federation. Antibiotiki i khimioterapia = Antibiotics and Chemotherapy, 2000, vol. 61, pp. 11–12. (In Russ.)]</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Кузина Е.С., Асташкин Е.И., Лев А.И., Агеева Е.Н., Карцев Н.Н., Светоч Э.А., Фурсова Н.К. Интегроны классов 1 и 2 в госпитальных штаммах грамотрицательных бактерий, выделенных в Москве и регионах Российской Федерации // Молекулярная генетика, микробиология и вирусология. 2019. Т. 37, № 1. С. 17–24. [Kuzina E.S., Astashkin E.I., Lev A.I., Ageeva E.N., Kartsev N.N., Svetoch E.A., Fursova N.K. Class 1 and class 2 integrons in hospital strains of gram-negative bacteria isolated in Moscow and other regions of the Russian Federation. Molekulyarnaya genetika, mikrobiologiya i virusologiya = Molecular Genetics, Microbiology and Virology, 2019, vol. 37, no 1, pp. 17–24. (In Russ.)] doi: 10.17116/molgen20193701117</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Семенова Д.Р., Николаева И.В., Фиалкина С.В., Хаертынов Х.С., Анохин В.А., Валиуллина И.Р. Частота колонизации «гипервирулентными» штаммами Klebsiella pneumoniae новорожденных и грудных детей с внебольничной и нозокомиальной клебсиеллезной инфекцией // Российский вестник перинатологии и педиатрии. 2020. Т. 65, № 5. С. 158–163. [Semenova D.R., Nikolaeva I.V., Fialkina S.V., Khaertynov K.S., Anohin V.A., Valiullina I.R. Frequency of colonization with “hypervirulent” Klebsiella pneumoniae strains of newborns and infants with community-acquired and nosocomial klebsiella infection. Rossiyskiy Vestnik Perinatologii i Pediatrii = Russian Bulletin of Perinatology and Pediatrics, 2020, vol. 65, no. 5, pp. 158–163. (In Russ.)] doi: 10.21508/1027-4065-2020-65-5-158-163</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Сергевнин В.И., Кудрявцева Л.Г., Пегушина О.Г. Частота выявления и антибиотикорезистентность возбудителей гнойно-септических инфекций // Эпидемиология и вакцинопрофилактика. 2022. Т. 21, № 1. С. 74–80. [Sergevnin V.I., Kudryavtseva L.G., Pegyshina O.G. Rate of detection and antibiotic resistance pathogens of purulent-septic infections in cardiac surgery patients. Epidemiologiya i vaktsinoprofilaktika = Epidemiology and Vaccine Prevention, 2022, vol. 21, no. 1, pp. 74–80. (In Russ.)] doi: 10.31631/2073-3046-2022-21-1-74-80</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Чеботарь И.В., Бочарова Ю.А., Подопригора И.В., Шагин Д.А. Почему Klebsiella pneumoniae становится лидирующим оппортунистическим патогеном // Клиническая микробиология и антимикробная химиотерапия. 2020. Т. 22, № 1. С. 4–19. [Chebotar I.V., Bocharova Yu.A., Podoprigora I.V., Shagin D.A. The reasons why Klebsiella pneumoniae becomes a leading opportunistic pathogen. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy, 2020, vol. 22, no. 1, pp. 4–19. (In Russ.)] doi: 10.36488/cmac.2020.1.4-19</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bhatt P.J., Ali M., Rana M., Patel G., Sullivan T., Murphy J., Pinney S., Anyanwu A., Huprikar S., Taimur S. Infections due to multidrug-resistant organisms following heart transplantation: epidemiology, microbiology, and outcomes. Transpl. Infect. Dis., 2020, vol. 22, no. 1: e13215. doi: 10.1111/tid.13215</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Gonçalves Barbosa L.C., Silva E Sousa J.A., Bordoni G.P., Barbosa G.O., Carneiro L.C. Elevated mortality risk from CRKp associated with comorbidities: systematic review and meta-analysis. Antibiotics (Basel)., 2022, vol. 11, no. 7: 874. doi: 10.3390/antibiotics11070874</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Chang D., Sharma L., Dela Cruz C.S., Zhang D. Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front. Microbiol., 2021, vol. 12: 750662. doi: 10.3389/fmicb.2021.750662</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Del Puente F., Giacobbe D.R., Salsano A., Maraolo A.E., Ong D.S.Y., Yusuf E., Tutino S., Marchese A., Santini F., Viscoli C. Epidemiology and outcome of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review. J. Chemother., 2019, vol. 31, no. 7–8, pp. 359–366. doi: 10.1080/1120009X.2019.1685794</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Edelstein M., Pimkin M., Palagin I., Edelstein I., Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother., 2003, vol. 47, no. 12, pp. 3724–3732. doi: 10.1128/aac.47.12.3724-3732.2003</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Fang C.T., Chuang Y.P., Shun C.T., Chang S.C., Wang J.T. A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. J. Exp. Med., 2004, vol. 199, no. 5, pp. 697–705. doi: 10.1084/jem.20030857</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Galvão L.M., Oliveira A.P.R., Ibanês A.S., Monteiro J., Inoue F., Dantas D.C., Sanchez F., Santos D.W., Abboud C.S. Fatal case of donor-derived colistin-resistant carbapenemase-producing Klebsiella pneumoniae transmission in cardiac transplantation. Braz. J. Infect. Dis., 2018, vol. 22. no. 3, pp. 235–238. doi: 10.1016/j.bjid.2018.04.005</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ghanizadeh A., Najafizade M., Rashki S., Marzhoseyni Z., Motallebi M. Genetic diversity, antimicrobial resistance pattern, and biofilm formation in Klebsiella pneumoniae Isolated from patients with coronavirus disease 2019 (COVID-19) and ventilator-associated pneumonia. Biomed. Res. Int., 2021, vol. 2021: 2347872. doi: 10.1155/2021/2347872</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Gorrie C.L., Mirčeta M., Wick R.R., Judd L.M., Lam M.M.C., Gomi R., Abbott I.J., Thomson N.R., Strugnell R.A., Pratt N.F., Garlick J.S., Watson K.M., Hunter P.C., Pilcher D.V., McGloughlin S.A., Spelman D.W., Wyres K.L., Jenney A.W.J., Holt K.E. Genomic dissection of Klebsiella pneumoniae infections in hospital patients reveals insights into an opportunistic pathogen. Nat. Commun., 2022, vol. 13, no. 1: 3017. doi: 10.1038/s41467-022-30717-6</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Grigoryev E.V., Shukevich D.L., Matveeva V.G., Kornekyuk R.A. Immunosuppression as a component of multiple organ dysfunction syndrome followed cardiac surgery. Complex Issues of Cardiovascular Diseases, 2018, vol. 7 no. 4, pp. 84–91. doi: 10.17802/2306-1278-2018-7-4-84-91</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Gu D., Dong N., Zheng Z., Lin D., Huang M., Wang L., Chan E.W., Shu L., Yu J., Zhang R., Chen S. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect. Dis., 2018, vol. 18, no. 1, pp. 37–46. doi: 10.1016/S1473-3099(17)30489-9</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Huey B., Hall J., Hypervariable DNA fingerprinting in Escherichia coli: minisatellite probe from bacteriophage M13. J. Bacteriol., 1989, vol. 171, no. 5, pp. 2528–2532. doi: 10.1128/jb.171.5.2528-2532.1989</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Kundu J., Kansal S., Rathore S., Kaundal M., Angrup A., Biswal M., Walia K., Ray P., Evaluation of ERIC-PCR and MALDI-TOF as typing tools for multidrug resistant Klebsiella pneumoniae clinical isolates from a tertiary care center in India. PLoS One, 2022, vol. 17, no. 11: e0271652. doi: 10.1371/journal.pone.0271652</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lazareva I., Ageevets V., Sopova J., Lebedeva M., Starkova P., Likholetova D., Gostev V., Moiseenko V., Egorenkov V., Navatskaya A., Mitroshina G., Myasnikova E., Tsvetkova I., Lobzin Y., Sidorenko S. The emergence of hypervirulent blaNDM-1-positive Klebsiella pneumoniae sequence type 395 in an oncology hospital. Infect. Genet. Evol., 2020, vol. 85: 104527. doi: 10.1016/j.meegid.2020.104527</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Lev A.I., Astashkin E.I., Kislichkina A.A., Solovieva E.V., Kombarova T.I., Korobova O.V., Ershova O.N., Alexandrova I.A., Malikov V.E., Bogun A.G., Borzilov A.I., Volozhantsev N.V., Svetoch E.A., Fursova N.K. Comparative analysis of Klebsiella pneumoniae strains isolated in 2012–2016 that differ by antibiotic resistance genes and virulence genes profiles. Pathog. Glob. Health., 2018, vol. 112, no. 3, pp. 142–151. doi: 10.1080/20477724.2018.1460949</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Liu C., Du P., Xiao N., Ji F, Russo T.A., Guo J. Hypervirulent Klebsiella pneumoniae is emerging as an increasingly prevalent K. pneumoniae pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China. Virulence, 2020, vol. 11, no. 1, pp. 1215–1224. doi: 10.1080/21505594.2020.1809322</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Lombardi F., Gaia P., Valaperta R., Cornetta M., Tejada M.R., Di Girolamo L., Moroni A., Ramundo F., Colombo A., Valisi M., Costa E. Emergence of carbapenem-resistant Klebsiella pneumoniae: progressive spread and four-year period of observation in a cardiac surgery division. Biomed. Res. Int., 2015, vol. 2015: 871947. doi: 10.1155/2015/871947</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., Paterson D.L., Rice L.B., Stelling J., Struelens M.J., Vatopoulos A., Weber J.T., Monnet D.L. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect., 2012, vol. 18, pp. 268–281. doi: 10.1111/j.1469-0691.2011.03570.x</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Martin R.M., Bachman M.A. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front. Cell. Infect. Microbiol., 2018, vol. 8, no. 4. doi: 10.3389/fcimb.2018.00004</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Meacham K.J., Zhang L., Foxman B., Bauer R.J., Marrs C.F. Evaluation of genotyping large numbers of Escherichia coli isolates by enterobacterial repetitive intergenic consensus-PCR. J. Clin. Microbiol., 2003, vol. 41, no. 11, pp. 5224–5226. doi: 10.1128/JCM.41.11.5224-5226.2003</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Navon-Venezia S., Kondratyeva K., Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol. Rev., 2017, vol. 41, no. 3, pp. 252–275. doi: 10.1093/femsre/fux013</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Pendleton J.N., Gorman S.P., Gilmore B.F. Clinical relevance of the ESKAPE pathogens. Expert. Rev. Anti Infect. Ther., 2013, vol. 11, no. 3, pp. 297–308. doi: 10.1586/eri.13.12</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Pierce G., Resch C., Mourin M., Dibrov P., Dibrov E., Ravandi A. Bacteria and the growing threat of multidrug resistance for invasive cardiac interventions. Rev. Cardiovasc. Med., 2022, vol. 23, no. 1: 15. doi: 10.31083/j.rcm2301015</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Podschun R., Ullmann U. Klebsiella spp as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev., 1998, vol. 11, no. 4, pp. 589–603. doi: 10.1128/CMR.11.4.589</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Poerio N., Olimpieri T., Henrici De Angelis L., De Santis F., Thaller M.C., D’Andrea M.M., Fraziano M. Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach. Front. Immunol., 2022, vol. 13: 835417. doi: 10.3389/fimmu.2022.835417</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Purighalla S., Esakimuthu S., Reddy M., Varghese G.K., Richard V.S., Sambandamurthy V.K. Discriminatory power of three typing techniques in determining relatedness of nosocomial Klebsiella pneumoniae isolates from a tertiary hospital in India. Indian. J.Med. Microbiol., 2017, vol. 35, no. 3, pp. 361–368. doi: 10.4103/ijmm.IJMM_16_308</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Qin Ou, Wenfang Li, Bei Li, Chunfang Yu. Prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) and the distribution of Class 1 Integron in their strains isolated from a hospital in Central China. Chin. Med. Sci. J., 2017, vol. 32, no. 2, pp. 107–112. doi: 10.24920/J1001-9294.2017.018</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Russo T.A., Marr C.M. Hypervirulent Klebsiella pneumoniae. Clin. Microbiol. Rev., 2019, vol. 32, no 3, pp. e00001–e000019. doi: 10.1128/CMR.00001-19</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Russo T.A., Olson R., Fang C.T., Stoesser N., Miller M., MacDonald U., Hutson A., Barker J.H., La Hoz R.M., Johnson J.R. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J. Clin. Microbiol., 2018, vol. 56, no. 9. doi: 10.1128/JCM.00776-18</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Versalovic J., Koeuth T., Lupski J.R. Distribution of repetitive DNA sequences in Eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res., 1991, vol. 19, pp. 6823–6831. doi: 10.1093/nar/19.24.6823</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Wang Q., Li B., Tsang A.K., Yi Y., Woo P.C., Liu C.H. Genotypic analysis of Klebsiella pneumoniae isolates in a Beijing Hospital reveals high genetic diversity and clonal population structure of drug-resistant isolates. PLoS One, 2013, vol. 8, no. 2: e57091. doi: 10.1371/journal.pone.0057091</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Yeh K.M., Kurup A., Siu L.K., Koh Y.L., Fung C.P., Lin J.C., Chen T.L., Chang F.Y., Koh T.H. Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan. J. Clin. Microbiol., 2007, vol. 45, no. 2, pp. 466–471. doi: 10.1128/JCM.01150-06</mixed-citation></ref></ref-list></back></article>
